This bill modifies the National Security Commission on Emerging Biotechnology, a group established by the 2022 National Defense Authorization Act to evaluate biotechnology risks and opportunities relevant to national security. The legislation makes three key changes: it ensures that commission member appointments remain valid even if some positions aren't filled, it extends the commission's reporting deadline by six months beyond its original three-year timeline, and it extends the commission's overall sunset date to December 31, 2026. The bill essentially keeps the commission functioning longer than originally planned and provides additional time for it to complete its work. The changes affect the commission's operations and its ability to continue advising Congress and the Department of Defense on biotechnology policy matters related to national security.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.